| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32835901_HAS_TOPIC_C0020964> <https://research.tib.eu/covid-19/entity/32835901_HAS_TOPIC_C0026769> <https://research.tib.eu/covid-19/entity/32835901_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/32835901_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32835901_HAS_TOPIC_C0238598> <https://research.tib.eu/covid-19/entity/32835901_HAS_TOPIC_C0751324> <https://research.tib.eu/covid-19/entity/32835901_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32835901_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32835901_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Universidad del Desarrollo-Clínica Alemana, Santiago, Chile.\', \'Department of Neurology, Clínica Alemana, Santiago, Av Vitacura 5951, Vitacura, Santiago, Chile. Electronic address: lornag@gmail.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Fiorella_Celsi> <https://research.tib.eu/covid-19/entity/Lorna_Galleguillos>
?:doi	<https://research.tib.eu/covid-19/entity/S2211-0348%2820%2930522-810.1016/j.msard.2020.102447>
?:doi	S2211-0348(20)30522-810.1016/j.msard.2020.102447
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Case_Reports> <https://research.tib.eu/covid-19/entity/Letter>
?:journal	Multiple sclerosis and related disorders
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32835901>
?:pmid	<https://research.tib.eu/covid-19/entity/32835901>
?:pmid	32835901
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.123
?:rankingScore_hIndex	18
?:title	COVID-19 in a multiple sclerosis (MS) patient treated with alemtuzumab: Insight to the immune response after COVID.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32835901>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32835901>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all